PTX3 is regulated by two enhancers in CRC: enhancer 1 is epigenetically silenced by STAT3 in early stages, whereas enhancer 2 undergoes stage-dependent DNA methylation during CRC progression. Here, STAT3 is linked to colorectal carcinoma.